1308285-21-3

1308285-21-3 structure

Name: Sildenafil Mesylate
Chemical Name: WIN 55,212-2 MESYLATE
CAS Number: 1308285-21-3
Molecular Formula: C₂₃H₃₄N₆O₇S₂
Molecular Weight: 570.68
Catalog: Signaling Pathways Metabolic Enzyme/Protease Phosphodiesterase (PDE)
Create Date: 2018-10-31 16:23:03
Modify Date: 2024-01-09 11:47:34
Sildenafil Mesylate is an orally active and selective phosphodiesterase type 5 (PDE5) inhibitor. Sildenafil Mesylate can be used in studies of erectile dysfunction and cancer[1].

Name	WIN 55,212-2 MESYLATE
Synonyms	5-{2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl}-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one methanesulfonate (1:1) 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,4-dihydro-1-methyl-3-propyl-, methanesulfonate (1:1) MFCD09753069

Description	Sildenafil Mesylate is an orally active and selective phosphodiesterase type 5 (PDE5) inhibitor. Sildenafil Mesylate can be used in studies of erectile dysfunction and cancer[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Metabolic Enzyme/Protease >> Phosphodiesterase (PDE)
References	[1]. Haider M, et al. The Potential Role of Sildenafil in Cancer Management through EPR Augmentation. J Pers Med. 2021 Jun 21;11(6):585.